Resona Asset Management Co. Ltd. purchased a new position in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 18,080 shares of the company's stock, valued at approximately $5,265,000.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Wellington Management Group LLP raised its position in shares of Molina Healthcare by 7.4% during the fourth quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company's stock worth $766,111,000 after purchasing an additional 181,073 shares during the period. Geode Capital Management LLC grew its holdings in shares of Molina Healthcare by 2.5% during the fourth quarter. Geode Capital Management LLC now owns 1,436,909 shares of the company's stock valued at $417,144,000 after buying an additional 34,992 shares during the last quarter. Norges Bank bought a new stake in shares of Molina Healthcare during the fourth quarter worth about $134,675,000. Charles Schwab Investment Management Inc. increased its position in shares of Molina Healthcare by 2.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 400,080 shares of the company's stock worth $116,443,000 after acquiring an additional 10,002 shares in the last quarter. Finally, Los Angeles Capital Management LLC raised its holdings in shares of Molina Healthcare by 166.1% in the 4th quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company's stock worth $57,195,000 after acquiring an additional 122,674 shares during the last quarter. Institutional investors own 98.50% of the company's stock.
Molina Healthcare Stock Performance
NYSE:MOH traded down $3.21 on Monday, reaching $341.79. 85,587 shares of the company's stock were exchanged, compared to its average volume of 652,440. The firm has a market cap of $18.70 billion, a price-to-earnings ratio of 16.73, a P/E/G ratio of 1.06 and a beta of 0.70. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62. The stock has a fifty day simple moving average of $310.39 and a 200-day simple moving average of $307.97. Molina Healthcare, Inc. has a 52 week low of $262.32 and a 52 week high of $373.22.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, sell-side analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current year.
Insider Activity
In related news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total value of $301,330.00. Following the transaction, the director now owns 17,375 shares of the company's stock, valued at $5,235,608.75. This represents a 5.44 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 1.10% of the company's stock.
Analysts Set New Price Targets
A number of brokerages have commented on MOH. Mizuho boosted their price objective on Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $350.00 price objective (down from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Wells Fargo & Company upgraded shares of Molina Healthcare from an "equal weight" rating to an "overweight" rating and increased their target price for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. Stephens restated an "equal weight" rating and set a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. Finally, UBS Group decreased their price objective on shares of Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Seven analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Molina Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $355.75.
Check Out Our Latest Report on Molina Healthcare
Molina Healthcare Company Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Featured Stories

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.